US Patent 11524066 Henipavirus vaccine
Patent 11524066 was granted and assigned to CureVac on December, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 22, 2017
0
Date of Patent
December 13, 2022
0
Patent Applicant
Patent Application Number
16471541
0
Patent Inventor Names
Benjamin Petsch
0
Edith Jasny
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11524066 Henipavirus vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
